Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1995-4-26
|
pubmed:abstractText |
We evaluated the expansion capacity of untreated and 5-fluorouracil (5-FU)-resistant peripheral blood stem cells (PBSC) after 7-day incubation with interleukin-1 (IL-1) plus IL-3 plus stem cell factor (SCF) or with medium alone. We found a significant increase in the proportion of CD34+ cells in the PBSC fraction resistant to 25 micrograms/mL 5-FU after 7-day incubation with IL-1 plus IL-3 plus SCF as compared with the untreated fraction (p = 0.011). We also showed that 5-FU-resistant PBSC have a greater capacity for expansion of IL-1/IL-3/SCF-responsive immature progenitors (p = 0.05), amplification of IL-3 plus GM-CSF responsive progenitors (p = 0.01), and production of committed single growth factor-responsive (granulocyte-macrophage colony-stimulating factor [GM-CSF]) precursors (p = 0.01) than the untreated PBSC. The expansion of all types of progenitors and CD34+ cells was only observed after 7-day incubation with IL-1 plus IL-3 plus SCF. These results suggest that PBSC contain a primitive stem cell population with an enhanced expansion capacity that is identified by 5-FU resistance. As these cells can be expanded in vitro, they may then be suitable for a number of clinical applications.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Hematopoietic Cell Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-3,
http://linkedlifedata.com/resource/pubmed/chemical/Stem Cell Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0301-472X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
303-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7534710-Antigens, CD,
pubmed-meshheading:7534710-Antigens, CD34,
pubmed-meshheading:7534710-Blood Cells,
pubmed-meshheading:7534710-Cell Cycle,
pubmed-meshheading:7534710-Cell Separation,
pubmed-meshheading:7534710-Cytapheresis,
pubmed-meshheading:7534710-Drug Resistance,
pubmed-meshheading:7534710-Fluorouracil,
pubmed-meshheading:7534710-Hematopoietic Cell Growth Factors,
pubmed-meshheading:7534710-Hematopoietic Stem Cells,
pubmed-meshheading:7534710-Humans,
pubmed-meshheading:7534710-Interleukin-1,
pubmed-meshheading:7534710-Interleukin-3,
pubmed-meshheading:7534710-Stem Cell Factor
|
pubmed:year |
1995
|
pubmed:articleTitle |
Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells.
|
pubmed:affiliation |
Laboratoire de Greffe de Moelle, Université de Bordeaux II, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|